Centers for Disease Control and Prevention - ERA

Description

This funding opportunity announcement (FOA) will support a factorial design randomized controlled trial (RCT) to evaluate the effectiveness of Assessment, Feedback, Incentives, eXchange (AFIX) and remote Physician-to-Physician (P2P) vaccine provider engagement strategies to increase adolescent human papillomavirus (HPV) vaccination rates and monitor the impact of immunization service delivery of other adolescent vaccines, i.e., tetanus-diphtheria-acellular pertussis (Tdap), meningococcal conjugate (MenACWY), and influenza (Flu), by vaccine providers serving the Vaccines for Children (VFC) program in one or more state, local and territorial public health jurisdictions.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education

Contact

Deborah Loveys<br/>hft6@cdc.gov<br/>
hft6@cdc.gov